BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33713485)

  • 21. Additive effects of a sodium chloride restricted diet and furosemide administration in healthy dogs.
    Lovern CS; Swecker WS; Lee JC; Moon ML
    Am J Vet Res; 2001 Nov; 62(11):1793-6. PubMed ID: 11703026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
    Tylicki L; Rutkowski P; Renke M; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
    Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the V(2)-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats.
    Hirano T; Yamamura Y; Nakamura S; Onogawa T; Mori T
    J Pharmacol Exp Ther; 2000 Jan; 292(1):288-94. PubMed ID: 10604960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
    van Vliet AA; Hackeng WH; Donker AJ; Meuwissen SG
    J Hepatol; 1992 May; 15(1-2):40-7. PubMed ID: 1324274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intermittent bolus injection versus continuous infusion of furosemide in normal adult greyhound dogs.
    Adin DB; Taylor AW; Hill RC; Scott KC; Martin FG
    J Vet Intern Med; 2003; 17(5):632-6. PubMed ID: 14529128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute effect of pimobendan and furosemide on the circulating renin-angiotensin-aldosterone system in healthy dogs.
    Sayer MB; Atkins CE; Fujii Y; Adams AK; DeFrancesco TC; Keene BW
    J Vet Intern Med; 2009; 23(5):1003-6. PubMed ID: 19737179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the renin-angiotensin-aldosterone system for control of arterial blood pressure following moderate deficit in total body sodium: balance studies in freely moving dogs.
    Seeliger E; Lunenburg T; Ladwig M; Reinhardt HW
    Clin Exp Pharmacol Physiol; 2010 Feb; 37(2):e43-51. PubMed ID: 19930429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic and pharmacodynamic properties of orally administered torasemide in healthy cats.
    Roche-Catholy M; Paepe D; Devreese M; Broeckx BJG; Woehrlé F; Schneider M; de Salazar Alcala AG; Hellemans A; Smets P
    J Vet Intern Med; 2022 Sep; 36(5):1782-1791. PubMed ID: 35906901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating renin-angiotensin-aldosterone system activity in cats with systemic hypertension or cardiomyopathy.
    Ward JL; Guillot E; Domenig O; Ware WA; Yuan L; Mochel JP
    J Vet Intern Med; 2022 May; 36(3):897-909. PubMed ID: 35285549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of combined AT1 receptor and aldosterone receptor antagonism on plasminogen activator inhibitor-1.
    Sawathiparnich P; Murphey LJ; Kumar S; Vaughan DE; Brown NJ
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3867-73. PubMed ID: 12915681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Furosemide continuous rate infusion diluted with 5% dextrose in water or hypertonic saline in normal adult dogs: a pilot study.
    Adin D; Atkins C; Papich M; DeFrancesco T; Griffiths E; Penteado M; Kurtz K; Klein A
    J Vet Cardiol; 2017 Feb; 19(1):44-56. PubMed ID: 27840084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
    Onogawa T; Sakamoto Y; Nakamura S; Nakayama S; Fujiki H; Yamamura Y
    Cardiovasc Drugs Ther; 2011 Dec; 25 Suppl 1():S67-76. PubMed ID: 22120095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism.
    Adin D; Atkins C; Domenig O; DeFrancesco T; Keene B; Tou S; Stern JA; Meurs KM
    J Vet Intern Med; 2020 Mar; 34(2):600-606. PubMed ID: 32112596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal response to acute diuresis--a comparative study of furosemide and azosemide.
    Ogawa K; Hatano T; Yamamoto M; Matsui N
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):284-90. PubMed ID: 6378806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Renin and aldosterone secretion under converting enzyme inhibition].
    Nakamura K
    Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1099-116. PubMed ID: 6141075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chemical profiling of aqueous soluble fraction from Lagopsis supina and its diuretic effects via suppression of AQP and RAAS pathways in saline-loaded rats.
    Yang L; He ZW; He JW
    J Ethnopharmacol; 2021 May; 272():113951. PubMed ID: 33610702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
    Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K
    Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.